Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Antibiotic Prophylaxis After Acute Pyelonephritis in Children With VUR
NCT00382343Phase 4Completed
- Sponsor
- IRCCS Burlo Garofolo
- Start
- Nov 1999
- Primary completion
- Mar 2003
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of trimethoprim + sulfamethoxazole in pyelonephritis and renal scarring (2 arms), sponsored by IRCCS Burlo Garofolo. Primary endpoint: Recurrence of pyelonephritis at 4 years. Started Nov 1999; status: completed.
02
Drugs
trimethoprim + sulfamethoxazole
03
Conditions
pyelonephritisrenal scarring
Beyond the preview
Go deeper on NCT00382343.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00382343.